FDA warns antiviral Hepatitis C drug users risk reactivation
Wednesday, October 5, 2016 - 14:03
in Health & Medicine
Ryan MaassWASHINGTON, Oct. 5 (UPI) -- According to FDA officials, patients using direct-acting antiviral medicines for hepatitis C may end up reactivating the disease in the form of hepatitis B.